2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... : Reduce risk of ... exacerbations Drug Class ... Eosinophils < 100 Dosing ... : 250 mcg tablet
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... ASA class If ... event, follow ACC algorithm ... Stable patients ... the type of and indication